
Martis Capital
Description
Martis Capital is a specialized private equity firm based in Palo Alto, California, and Washington D.C., exclusively focused on the healthcare industry. Founded in 2011, the firm targets middle-market companies, aiming to partner with management teams to drive growth and create value. Their investment philosophy centers on identifying established businesses with strong fundamentals and significant growth potential within the fragmented and evolving healthcare sector.
The firm employs a flexible investment approach, engaging in a range of transaction types including growth equity investments, leveraged buyouts, and recapitalizations. Martis Capital seeks to invest in companies that provide services, products, or technology across various healthcare sub-sectors, such as healthcare IT, outsourced services, specialty distribution, and multi-site healthcare providers. They typically target companies with enterprise values ranging from approximately $50 million to $500 million, indicating their commitment to the middle-market segment.
Martis Capital is known for its disciplined fundraising and deployment strategy. Their most recent fund, Martis Partners IV, successfully closed in 2021 with $540 million in committed capital, demonstrating continued investor confidence. Prior to this, Martis Partners III closed at $380 million in 2017, and Martis Partners II at $250 million in 2014, showcasing a consistent growth in fund size. For individual transactions, Martis Capital typically deploys equity checks between $25 million and $100 million, making them a significant capital partner for middle-market healthcare businesses. This range allows them to be the lead investor or a substantial co-investor in their target opportunities.
Investor Profile
Martis Capital has backed more than 21 startups, with 1 new investments in the last 12 months alone. The firm has led 8 rounds, about 38% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Private Equity, Series Unknown, Series F rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Medical, Biotechnology.
- Typical check size: $25M – $100M.
Stage Focus
- Private Equity (67%)
- Series Unknown (14%)
- Series F (5%)
- Post Ipo Equity (5%)
- Series E (5%)
- Convertible Note (5%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Medical
- Biotechnology
- Health Diagnostics
- Consulting
- Pharmaceutical
- Hospital
- Artificial Intelligence (Ai)
- Software
- Information Technology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.